AAPL330.87-7.45 (-2.20%) ▼|ABBV288.87+0.03 (+0.01%) ▲|ABT109.87-0.30 (-0.27%) ▼|ACN255.64-5.31 (-2.03%) ▼|ADBE247.76-3.71 (-1.48%) ▼|AMAT381.61+7.08 (+1.89%) ▲|AMD491.58+24.74 (+5.30%) ▲|AMGN463.55-1.90 (-0.41%) ▼|AMT186.55-1.75 (-0.93%) ▼|AMZN250.80+5.17 (+2.10%) ▲|AVGO332.19+9.96 (+3.09%) ▲|AXP325.63-2.35 (-0.72%) ▼|BA175.03-0.38 (-0.21%) ▼|BAC49.87+0.30 (+0.60%) ▲|BKNG151.23-2.52 (-1.64%) ▼|BLK1,165.77-1.38 (-0.12%) ▼|BMY62.22-0.80 (-1.27%) ▼|BNY150.09+2.31 (+1.56%) ▲|BRK-B559.36+3.25 (+0.58%) ▲|C122.13-0.97 (-0.79%) ▼|CAT625.25+11.63 (+1.90%) ▲|CL95.85-1.58 (-1.62%) ▼|CMCSA23.58-0.30 (-1.24%) ▼|COF208.47-2.30 (-1.09%) ▼|COP144.75-2.09 (-1.42%) ▼|COST1,021.08-19.47 (-1.87%) ▼|CRM223.08-3.10 (-1.37%) ▼|CSCO103.69+2.08 (+2.04%) ▲|CVS90.20+1.69 (+1.91%) ▲|CVX226.19-1.58 (-0.69%) ▼|DE673.22+5.62 (+0.84%) ▲|DHR231.77+3.80 (+1.67%) ▲|DIS113.94+0.83 (+0.73%) ▲|DUK127.18-1.20 (-0.93%) ▼|EMR165.99+0.03 (+0.02%) ▲|FDX321.64+3.39 (+1.07%) ▲|GD375.38+1.92 (+0.51%) ▲|GE320.56+4.78 (+1.51%) ▲|GEV926.25+64.00 (+7.42%) ▲|GILD169.49-0.84 (-0.49%) ▼|GM88.53-1.41 (-1.57%) ▼|GOOG279.49+1.45 (+0.52%) ▲|GOOGL280.64+1.65 (+0.59%) ▲|GS896.93-1.79 (-0.20%) ▼|HD332.19-8.96 (-2.63%) ▼|HON224.89+1.12 (+0.50%) ▲|IBM249.46-3.05 (-1.21%) ▼|INTC60.35+0.38 (+0.63%) ▲|INTU348.99-3.11 (-0.88%) ▼|ISRG441.38+4.51 (+1.03%) ▲|JNJ267.50-3.06 (-1.13%) ▼|JPM337.90-2.68 (-0.79%) ▼|KO95.15-0.68 (-0.71%) ▼|LIN515.24-4.48 (-0.86%) ▼|LLY1,420.50+9.51 (+0.67%) ▲|LMT644.06+0.91 (+0.14%) ▲|LOW213.83-4.32 (-1.98%) ▼|LRCX230.11+2.55 (+1.12%) ▲|MA650.19-7.91 (-1.20%) ▼|MCD262.68-2.96 (-1.11%) ▼|MDLZ65.53-0.86 (-1.29%) ▼|MDT99.18-0.11 (-0.11%) ▼|META623.24+16.51 (+2.72%) ▲|MMM177.53-0.84 (-0.47%) ▼|MO76.75-0.42 (-0.54%) ▼|MRK144.91-3.45 (-2.33%) ▼|MS186.17+0.44 (+0.24%) ▲|MSFT519.84+12.72 (+2.51%) ▲|MU849.52+15.93 (+1.91%) ▲|NEE84.35-0.69 (-0.81%) ▼|NFLX62.78+0.44 (+0.70%) ▲|NKE38.34-0.79 (-2.01%) ▼|NOW108.96+2.95 (+2.78%) ▲|NVDA207.71+5.65 (+2.80%) ▲|ORCL127.00+7.78 (+6.53%) ▲|PEP138.12-2.31 (-1.64%) ▼|PFE30.47-0.21 (-0.67%) ▼|PG162.11-1.46 (-0.89%) ▼|PLTR174.45-3.89 (-2.18%) ▼|PM208.54+0.25 (+0.12%) ▲|QCOM162.63+0.55 (+0.34%) ▲|RTX204.25+1.46 (+0.72%) ▲|SBUX104.22-0.18 (-0.17%) ▼|SCHW89.04+0.33 (+0.37%) ▲|SO94.24-0.37 (-0.39%) ▼|SPG220.85-0.88 (-0.40%) ▼|T21.28-0.16 (-0.75%) ▼|TMO697.92+15.27 (+2.24%) ▲|TMUS155.92-4.23 (-2.64%) ▼|TSLA397.93-5.90 (-1.46%) ▼|TXN313.09+11.07 (+3.67%) ▲|UBER66.54-0.18 (-0.26%) ▼|UNH404.68+4.24 (+1.06%) ▲|UNP304.39-2.61 (-0.85%) ▼|UPS109.15-0.56 (-0.51%) ▼|USB60.18-0.31 (-0.51%) ▼|V422.31-3.20 (-0.75%) ▼|VZ45.00-0.05 (-0.11%) ▼|WFC85.47-0.42 (-0.49%) ▼|WMT125.08-2.61 (-2.04%) ▼|XOM177.95-1.72 (-0.96%) ▼|AAPL330.87-7.45 (-2.20%) ▼|ABBV288.87+0.03 (+0.01%) ▲|ABT109.87-0.30 (-0.27%) ▼|ACN255.64-5.31 (-2.03%) ▼|ADBE247.76-3.71 (-1.48%) ▼|AMAT381.61+7.08 (+1.89%) ▲|AMD491.58+24.74 (+5.30%) ▲|AMGN463.55-1.90 (-0.41%) ▼|AMT186.55-1.75 (-0.93%) ▼|AMZN250.80+5.17 (+2.10%) ▲|AVGO332.19+9.96 (+3.09%) ▲|AXP325.63-2.35 (-0.72%) ▼|BA175.03-0.38 (-0.21%) ▼|BAC49.87+0.30 (+0.60%) ▲|BKNG151.23-2.52 (-1.64%) ▼|BLK1,165.77-1.38 (-0.12%) ▼|BMY62.22-0.80 (-1.27%) ▼|BNY150.09+2.31 (+1.56%) ▲|BRK-B559.36+3.25 (+0.58%) ▲|C122.13-0.97 (-0.79%) ▼|CAT625.25+11.63 (+1.90%) ▲|CL95.85-1.58 (-1.62%) ▼|CMCSA23.58-0.30 (-1.24%) ▼|COF208.47-2.30 (-1.09%) ▼|COP144.75-2.09 (-1.42%) ▼|COST1,021.08-19.47 (-1.87%) ▼|CRM223.08-3.10 (-1.37%) ▼|CSCO103.69+2.08 (+2.04%) ▲|CVS90.20+1.69 (+1.91%) ▲|CVX226.19-1.58 (-0.69%) ▼|DE673.22+5.62 (+0.84%) ▲|DHR231.77+3.80 (+1.67%) ▲|DIS113.94+0.83 (+0.73%) ▲|DUK127.18-1.20 (-0.93%) ▼|EMR165.99+0.03 (+0.02%) ▲|FDX321.64+3.39 (+1.07%) ▲|GD375.38+1.92 (+0.51%) ▲|GE320.56+4.78 (+1.51%) ▲|GEV926.25+64.00 (+7.42%) ▲|GILD169.49-0.84 (-0.49%) ▼|GM88.53-1.41 (-1.57%) ▼|GOOG279.49+1.45 (+0.52%) ▲|GOOGL280.64+1.65 (+0.59%) ▲|GS896.93-1.79 (-0.20%) ▼|HD332.19-8.96 (-2.63%) ▼|HON224.89+1.12 (+0.50%) ▲|IBM249.46-3.05 (-1.21%) ▼|INTC60.35+0.38 (+0.63%) ▲|INTU348.99-3.11 (-0.88%) ▼|ISRG441.38+4.51 (+1.03%) ▲|JNJ267.50-3.06 (-1.13%) ▼|JPM337.90-2.68 (-0.79%) ▼|KO95.15-0.68 (-0.71%) ▼|LIN515.24-4.48 (-0.86%) ▼|LLY1,420.50+9.51 (+0.67%) ▲|LMT644.06+0.91 (+0.14%) ▲|LOW213.83-4.32 (-1.98%) ▼|LRCX230.11+2.55 (+1.12%) ▲|MA650.19-7.91 (-1.20%) ▼|MCD262.68-2.96 (-1.11%) ▼|MDLZ65.53-0.86 (-1.29%) ▼|MDT99.18-0.11 (-0.11%) ▼|META623.24+16.51 (+2.72%) ▲|MMM177.53-0.84 (-0.47%) ▼|MO76.75-0.42 (-0.54%) ▼|MRK144.91-3.45 (-2.33%) ▼|MS186.17+0.44 (+0.24%) ▲|MSFT519.84+12.72 (+2.51%) ▲|MU849.52+15.93 (+1.91%) ▲|NEE84.35-0.69 (-0.81%) ▼|NFLX62.78+0.44 (+0.70%) ▲|NKE38.34-0.79 (-2.01%) ▼|NOW108.96+2.95 (+2.78%) ▲|NVDA207.71+5.65 (+2.80%) ▲|ORCL127.00+7.78 (+6.53%) ▲|PEP138.12-2.31 (-1.64%) ▼|PFE30.47-0.21 (-0.67%) ▼|PG162.11-1.46 (-0.89%) ▼|PLTR174.45-3.89 (-2.18%) ▼|PM208.54+0.25 (+0.12%) ▲|QCOM162.63+0.55 (+0.34%) ▲|RTX204.25+1.46 (+0.72%) ▲|SBUX104.22-0.18 (-0.17%) ▼|SCHW89.04+0.33 (+0.37%) ▲|SO94.24-0.37 (-0.39%) ▼|SPG220.85-0.88 (-0.40%) ▼|T21.28-0.16 (-0.75%) ▼|TMO697.92+15.27 (+2.24%) ▲|TMUS155.92-4.23 (-2.64%) ▼|TSLA397.93-5.90 (-1.46%) ▼|TXN313.09+11.07 (+3.67%) ▲|UBER66.54-0.18 (-0.26%) ▼|UNH404.68+4.24 (+1.06%) ▲|UNP304.39-2.61 (-0.85%) ▼|UPS109.15-0.56 (-0.51%) ▼|USB60.18-0.31 (-0.51%) ▼|V422.31-3.20 (-0.75%) ▼|VZ45.00-0.05 (-0.11%) ▼|WFC85.47-0.42 (-0.49%) ▼|WMT125.08-2.61 (-2.04%) ▼|XOM177.95-1.72 (-0.96%) ▼|
20.7 C
New York
Tuesday, November 3, 2026

Tag: statement

newsFORsourcecompanycontentinformationreleases1market

Qualigen Therapeutics Provides Update on Nasdaq Communications and Continued Listing Status

CARLSBAD, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) received two different communications from the staff of the Nasdaq Listing Qualifications office of the Nasdaq Stock Market, LLC. The Company received the first notice from the Nasdaq Listings Qualifications office of the Nasdaq Stock Market LLC on July 23, 2025, informing the Company that as reflected in the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 filed with the SEC on July 21, 2025, the Company failed to comply with the $2.5 million stockholder’s equity required under Nasdaq Rule 5550(b)(1) (the “Equity Rule”) or any alternative standard under Nasdaq 5550(b).

BlackLine Appoints Greg Hughes to Board of Directors, Expanding Enterprise Software and Strategic Growth Expertise

LOS ANGELES, July 29, 2025 /PRNewswire/ -- BlackLine, Inc. (Nasdaq: BL), the future-ready financial operations platform for the Office of the CFO, today announced...

Correction: iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering

WOBURN, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- This press release corrects a version issued on July 25, 2025 that incorrectly listed KCSA Strategic Communications as iSpecimen’s investor relations contact. KCSA is not currently affiliated with iSpecimen Inc. and was mistakenly included in the prior release. The corrected release is below in its entirety.

Universal Safety Products, Inc. (formerly Universal Security Instruments, Inc.) Announces its Fourth-Quarter and Year-End Results

OWINGS MILLS, Md., July 28, 2025 (GLOBE NEWSWIRE) -- Universal Safety Products, Inc. (formerly Universal Security Instruments, Inc.) (NYSE American LLC: UUU) today announced its financial results for the fourth quarter and its fiscal year ended March 31, 2025.

TOPAZ REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS DEMONSTRATING STRONG ROYALTY AND INFRASTRUCTURE GROWTH

CALGARY, AB, July 28, 2025 /CNW/ - Topaz Energy Corp. (TSX: TPZ) ("Topaz" or the "Company") is pleased to provide second quarter 2025 financial...

PTC Therapeutics Announces FDA Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU)

- Broad labeling inclusive of all disease subtypes for individuals 1 month of age and older - - PTC will host a conference call on...

Simpson Manufacturing Co., Inc. Announces 2025 Second Quarter Financial Results and Reaffirms 2025 Guidance

Net sales of $631.1 million increased 5.7% year-over-yearIncome from operations of $140.2 million increased 6.1% year-over-yearNet income per diluted share of $2.47 increased 6.9%...

Whirlpool Corporation Announces Second-Quarter Results

Delivered sequential net sales growth across all segments, despite negative consumer sentiment impacting global demandDelivered significant cost take out of 100 basis points or...

Biologic Therapeutics Market to Hit $794.5 Billion by 2029

"Driven by Rising Chronic Disease Burden and Breakthrough FDA Approvals, Biopharmaceutical Market Surges with Demand for Monoclonal Antibodies, Gene and Cell Therapies, and Innovative...

Piramal Pharma Limited Announces Results for Q1FY26

MUMBAI, India, July 28, 2025 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, and health and wellness company, today...

Biologic Therapeutics Market to Hit $794.5 Billion by 2029

"Driven by Rising Chronic Disease Burden and Breakthrough FDA Approvals, Biopharmaceutical Market Surges with Demand for Monoclonal Antibodies, Gene and Cell Therapies, and Innovative...

Mountain Province Diamonds Announces US$10 Million Additional Borrowings Under Bridge Facility

TSX and OTC: MPVD TORONTO and NEW YORK, July 28, 2025 /PRNewswire/ -- Mountain Province Diamonds Inc. ("Mountain Province" or the "Company") (TSX: MPVD) (OTC: MPVD) announces today that it has entered into an...

Mountain Province Diamonds Announces US$10 Million Additional Borrowings Under Bridge Facility

TSX and OTC: MPVD TORONTO and NEW YORK, July 28, 2025 /PRNewswire/ - Mountain Province Diamonds Inc. ("Mountain Province" or the "Company") (TSX: MPVD) (OTC: MPVD) announces today that it has entered into an...

Mountain Province Diamonds Announces US$10 Million Additional Borrowings Under Bridge Facility

TSX and OTC: MPVD TORONTO and NEW YORK, July 28, 2025 /CNW/ - Mountain Province Diamonds Inc. ("Mountain Province" or the "Company") (TSX: MPVD) (OTC: MPVD) announces today that it has entered into an...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsStatement

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers